SALT LAKE CITY, Feb. 8, 2012 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer focused on proprietary silicon nitride ceramic material platforms, today announced leadership appointments designed to drive the company's ambitious growth initiatives in the United States and abroad.
To support the clinical and commercialization activities that will drive the company's growth, Amedica has appointed orthopaedic surgeon B. Sonny Bal, M.D., M.B.A., J.D., to its Board of Directors.
"As we enter our next stage of development and look forward to commercializing new generation of products, having a forward-thinking industry leader, like Sonny, on the board of the company is invaluable to our organization," said Max Link, chairman of Amedica's Board of Directors.
Dr. Bal is an Associate Professor of Orthopaedic Surgery at the University of Missouri, Columbia, specializing in hip and knee replacement surgery. He also is an Adjunct Professor of Material Sciences at the University of Missouri at Rolla. Dr. Bal received his M.D. from Cornell University and an M.B.A. from Northwestern University, and is a licensed attorney who co-founded the Bal Brenner law firm in North Carolina. He is a member of the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, with over 100 scientific publications. In addition to guiding Amedica on the commercialization of its unique silicon nitride ceramic technologies, Bal will also recruit and lead Amedica's Adult Reconstructive and Spine Medical Advisory Boards.
"Amedica's silicon-nitride based devices offer unique clinical benefits that have enormous potential to improve device performance and, ultimately, patient outcomes," continued Link. "With Sonny's expertise, Amedica is well positioned to continue bringing to market the transformational technologies that will revolutionize orthopaedic and spine care in the future."
For more information about Amedica Corporation, visit www.amedica.com
About Amedica Corporation
Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy. Amedica is a privately held, private equity backed ceramic manufacturing and implant distribution company founded in 1996 by internationally recognized Orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its products are FDA cleared, CE marked and are sold in ten countries. Amedica Corporation is based in Salt Lake City, Utah.
SOURCE Amedica Corporation